On thursday 28 February 2008 the Dutch Parliamentary Justice Commission devoted its debate to the drugs UNGASS review. Martin Jelsma was invited as one of the experts to share with the commission TNI's views on the importance of the review process. In his contribution he highlights the opportunity to use the 2008/9 period to achieve a breakthrough on harm reduction acceptance at the UN level, to evaluate the performance of UN agencies like UNODC and the INCB, and to open the door for a revision of the UN drug control treaty system. only available in Dutch
The 50th Commission on Narcotic Drugs (CND), held in Vienna from 12-16 March 2007 was the last such event before the watershed year of 2008, when the international community will review progress against the objectives set at the General Assembly Special Session on Drugs (UNGASS), held in New York in 1998. The key decision that had to be taken at the 2007 CND was the timing and procedure for the UNGASS review.
The International AIDS Society (IAS) wrote a letter to the Chair of the Commission on Narcotics Drugs (CND) to express concern about the absence of language on harm reduction in the draft outcome documents to be adopted by the 52nd session of the Commission on Narcotic Drugs in March 2009.
The International AIDS Society is world’s leading independent association of HIV professionals with over 11,000 members from 183 countries; and the custodian of the International AIDS Conference to be held in Vienna in 2010.
UNDCPs 1998 plan to eradicate the cultivation of both coca and opium poppy by the year 2008 was a rare opportunity to re-think current drugs efforts. Member states were asked to endorse a plan, known as SCOPE, for the eradication of drugs-linked crops by 2008. Is SCOPE viable? And what impact would it have on poor farmers who grow drugs-linked crops to survive?
The International Drug Policy Consortium (IDPC) – of which TNI is a member – published a second version of its Advocacy Guide that provides an update on the emerging process for the review of global policies on controlled drugs being conducted under the auspices of the United Nations. It describes the latest situation on the planning for the review, and sets out the IDPC position on which issues need to be addressed in the review, and how these issues may be tackled in order to achieve a constructive outcome.
Conflicting views and policies within the UN system on harm reduction have become a major concern. Consistency in messages is crucial especially where it concerns joint global programmes such as the efforts to slow down the HIV/AIDS epidemic; efforts in which harm reduction practices like needle exchange and substitution treatment play a pivotal role.